In contrast, the Fluc signal from TRIM52-targeted tumors was significantly lower at these time points (∼4-fold; Figure 2A, and 2B), indicating that TRIM52-knockdown diminishes tumor growth. This evidence concerns the gene TRIM52 and neoplasm.